Evan D. Kharasch - Concepedia

Author

Evan D. Kharasch

Also Known As

E D Kharasch, E KHARASCH, E Kharasch, E. D. Kharasch, E. Kharasch, E.D. Kharasch, E. D. Kharasch, EVAN D. KHARASCH, Evan D Kharasch, Evan D. Kharasch

460

Publications

17.2K

Citations

H-Index

173

Concepts

All Affiliations

University of Washington Washington University in St. Louis University of Health Sciences and Pharmacy Duke University

About

Evan D. Kharasch is an author at University of Washington specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	71	3.7K
2	Health Sciences	16	16	1.6K
3	Engineering	15	17	864
4	Arts	1	1	19
5	Law	1	1	15

Evan D. Kharasch

232

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites Bojan Lalovic, Evan D. Kharasch, Danny D. Shen Clinical Pharmacology & Therapeutics	2006	412
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger, Clinical Pharmacology & Therapeutics Codeine TherapyPharmacotherapyCytochrome P450 2D6PharmacogenomicsDrug Toxicity	2011	367
Psychedelic Effects of Ketamine in Healthy Volunteers Andrew T. Bowdle, Allen D. Radant, Deborah S. Cowley, Anesthesiology	1998	366
Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy Kristine R. Crews, Andrew A. Monte, Rachel Huddart, Clinical Pharmacology & Therapeutics	2021	366
Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3 Kenneth E. Thummel, Cynthia Brimer, Kazuto Yasuda, Molecular Pharmacology	2001	323
Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and Methoxyflurane Evan D. Kharasch, Kenneth E. Thummel Anesthesiology	1993	312
Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Rita Labroo, Mary F. Paine, Kenneth E. Thummel, PubMed Amide HydrolysisMetabolomic ProfilingPharmacotherapyExperimental PharmacologyInterindividual Variability	1997	295
Bispectral Index Monitoring during Sedation with Sevoflurane, Midazolam, and Propofol Andra E. Ibrahim, Julie K. Taraday, Evan D. Kharasch Anesthesiology	2001	259
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone Evan D. Kharasch, C HOFFER, D WHITTINGTON, Clinical Pharmacology & Therapeutics	2004	237
Human Kidney Methoxyflurane and Sevoflurane Metabolism Evan D. Kharasch, Douglas C. Hankins, Kenneth E. Thummel Anesthesiology	1995	231

Page 1